Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-23

Clinical Trial Update: Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord Blood for Osteoarthritis Management [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating allogeneic mesenchymal stem cells derived from umbilical cord blood for knee osteoarthritis, sponsored by Indonesia University, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical cord blood-derived allogeneic mesenchymal stem cells

Snippet

Sponsor: Indonesia University | Conditions: Osteoarthritis, Knee | EARLY_Phase 1 | Status: UNKNOWN